A number of global Pharma companies have pulled out of the biotech SEZ project named Serum Bio-Pharma Park at Hadapsar in Pune (Maharahtra) due to uncertainty in government's policy leaving Pune based Serum Institute to go ahead with the project on its own.

The company has already invested Rs 1,000 crore in the biotech and pharmaceutical SEZ to get benefit of tax exemptions. The company operates about half of the plants constructed within the SEZ and plans to get the remaining half running by the end of this fiscal.

The project is being implemented in three phases and spread over 23 ha.

Related Links:
Project profile

← All latest storiesBack to top →